Loading...
XKRX
256840
Market cap248mUSD
Nov 13, Last price  
5,340.00KRW
1D
1.52%
1Q
5.53%
IPO
109.41%
Name

BNC Korea Co Ltd

Chart & Performance

D1W1MN
P/E
27.45
P/S
4.09
EPS
194.57
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
89.23b
+10.16%
80,997,489,68189,229,998,000
Net income
13.31b
-48.19%
25,686,082,03013,307,623,000
CFO
16.70b
+1.63%
16,429,270,69016,696,815,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BNC Korea Co., Ltd. engages in the research and development, production, and sale of biomaterials in South Korea. The company offers HA fillers and skin booster fillers, including Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, which are used to temporarily reduce facial wrinkles through physical restoration. It also provides Hibarry, a dressing for deep-cavity wounds that is used to reduce adhesion of the spinal cord during surgery; GENTA Q, a white collagen sponge, which is used to protect wounds by preventing contamination of wounds; and beauty solutions, face mask gels, mils cleansing foams, and brightening peeling gels. The company also exports its products to 45 countries. BNC Korea Co., Ltd. was founded in 2007 and is headquartered in Daegu, South Korea.
IPO date
Dec 28, 2016
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFY
2024‑122023‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT